Login / Signup

Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels.

Naif Khalaf Al HarbiFahad AljamaanHaya A AljamiMohammed W AlenaziHind AlbalawiAbdulrahman AlmasoudFatima J AlharthiEsam Ibraheem AzharTlili BarhoumiMohammad BosaeedSarah C GilbertAnwar M Hashem
Published in: Vaccines (2022)
MVA-MERS vaccine, administered in a homologous prime-boost regimen, induced high levels of neutralising anti-MERS-CoV antibodies in mice and camels. This could be considered for further development and evaluation as a dromedary vaccine to reduce MERS-CoV transmission to humans.
Keyphrases
  • respiratory syndrome coronavirus
  • sars cov
  • coronavirus disease
  • high dose
  • high fat diet induced
  • low dose
  • dna damage
  • type diabetes
  • dna repair
  • metabolic syndrome
  • skeletal muscle